Abstract
Intestinal microbial dysbiosis has been described in individuals with an HIV-1 infection and may underlie persistent inflammation in chronic infection, thereby contributing to disease progression. Herein, we induced an HIV-1-like intestinal dysbiosis in rhesus macaques (Macaca mulatta) with vancomycin treatment and assessed the contribution of dysbiosis to SIV disease progression. Dysbiotic and control animals had similar disease progression, indicating that intestinal microbial dysbiosis similar to that observed in individuals with HIV is not sufficient to accelerate untreated lentiviral disease progression.
Access options
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.


References
- 1.
Ortiz, A. M. & Brenchley, J. M. Curr. Opin. HIV AIDS 13, 15–21 (2018).
- 2.
Brenchley, J. M., Silvestri, G. & Douek, D. C. Immunity 32, 737–742 (2010).
- 3.
Noguera-Julian, M. et al. EBioMedicine 5, 135–146 (2016).
- 4.
Policicchio, B. B., Pandrea, I. & Apetrei, C. Front. Immunol. 7, 12 (2016).
- 5.
Mudd, J. C. & Brenchley, J. M. J. Infect. Dis. 214 Suppl 2, S58–S66 (2016).
- 6.
Ivanov, I. I. et al. Cell 139, 485–498 (2009).
- 7.
Kelly, C. J. et al. Cell Host Microbe 17, 662–671 (2015).
- 8.
Day, C. L. et al. Nature 443, 350–354 (2006).
- 9.
Betts, M. R. et al. Blood 107, 4781–4789 (2006).
- 10.
McKenna, P. et al. PLoS Pathog. 4, e20 (2008).
- 11.
Gosmann, C. et al. Immunity 46, 29–37 (2017).
- 12.
d’Ettorre, G. et al. Immun. Inflamm. Dis. 5, 244–260 (2017).
- 13.
Vujkovic-Cvijin, I. et al. Gut Microbes 8, 440–450 (2017).
- 14.
Hager, C. L. & Ghannoum, M. A. Curr. Opin. HIV AIDS 13, 69–72 (2018).
- 15.
Ortiz, A. M. et al. Mucosal Immunol. 9, 458–467 (2016).
- 16.
Caporaso, J. G. et al. Nat. Methods 7, 335–336 (2010).
- 17.
Langille, M. G. et al. Nat. Biotechnol. 31, 814–821 (2013).
- 18.
Estes, J. D. et al. PLoS Pathog. 6, e1001052 (2010).
- 19.
Hao, X. P. et al. Nat. Commun. 6, 8020 (2015).
- 20.
Brenchley, J. M. et al. Blood 120, 4172–4181 (2012).
- 21.
Segata, N. et al. Genome Biol. 12, R60 (2011).
- 22.
Parks, D. H., Tyson, G. W., Hugenholtz, P. & Beiko, R. G. Bioinformatics 30, 3123–3124 (2014).
Acknowledgements
We would like to acknowledge H. Kendall, J. Swerczek, R. Herbert, and all the veterinary staff at the NIH animal center. We would like to thank M. Quiñones, J. Davis, S. Sen and G. Trinchieri, and the NIAID Microbiome Program for technical and analytical assistance. Funding for this study was provided in part by the Division of Intramural Research/NIAID/NIH, by the Oregon National Primate Research Center NIH grant award P51OD011092, and with federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services (DHHS), nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Author information
Affiliations
Contributions
J.M.B. conceived the project. A.M.O. and J.M.B. designed the project and wrote the manuscript. A.M.O., J.K.F., S.R.D., C.E.C.S., S.H.L., M.E.L., O.S., C.L.V., J.C.M., L.J., K.B.-S., J.D.E. and J.M.B. performed experiments. A.M.O., J.K.F., S.R.D., I.V.-C., S.H.L., Y.B., J.D.E. and J.M.B. analyzed data.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8 and Supplementary Table 1
Supplementary Dataset 1
LEFSE returned results
Rights and permissions
About this article
Cite this article
Ortiz, A.M., Flynn, J.K., DiNapoli, S.R. et al. Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques. Nat Med 24, 1313–1316 (2018). https://doi.org/10.1038/s41591-018-0132-5
Received:
Accepted:
Published:
Issue Date:
Further reading
-
A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop
AIDS Research and Human Retroviruses (2020)
-
Diversity and Complexity of the Large Surface Protein Family in the Compacted Genomes of MultiplePneumocystisSpecies
mBio (2020)
-
Impact of Acute HIV Infection and Early Antiretroviral Therapy on the Human Gut Microbiome
Open Forum Infectious Diseases (2020)
-
HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration
Current HIV/AIDS Reports (2019)
-
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection
PLOS Pathogens (2019)